These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36047601)

  • 1. Proniosome: A Promising Approach for Vesicular Drug Delivery.
    Ajrin M; Anjum F
    Turk J Pharm Sci; 2022 Aug; 19(4):462-475. PubMed ID: 36047601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technology overview and drug delivery application of proniosome.
    Ahmad MZ; Mohammed AA; Mokhtar Ibrahim M
    Pharm Dev Technol; 2017 May; 22(3):302-311. PubMed ID: 26794727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single Intravenous Dose of Novel Flurbiprofen-Loaded Proniosome Formulations Provides Prolonged Systemic Exposure and Anti-inflammatory Effect.
    Verma P; Prajapati SK; Yadav R; Senyschyn D; Shea PR; Trevaskis NL
    Mol Pharm; 2016 Nov; 13(11):3688-3699. PubMed ID: 27632682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proniosomes derived niosomes: recent advancements in drug delivery and targeting.
    Khatoon M; Shah KU; Din FU; Shah SU; Rehman AU; Dilawar N; Khan AN
    Drug Deliv; 2017; 24(sup1):56-69. PubMed ID: 29130758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nano-proniosomes enhancing the transdermal delivery of mefenamic acid.
    Wen MM; Farid RM; Kassem AA
    J Liposome Res; 2014 Dec; 24(4):280-9. PubMed ID: 24779560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentials of proniosomes for improving the oral bioavailability of poorly water-soluble drugs.
    Song S; Tian B; Chen F; Zhang W; Pan Y; Zhang Q; Yang X; Pan W
    Drug Dev Ind Pharm; 2015 Jan; 41(1):51-62. PubMed ID: 24111828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation of Glibenclamide proniosomes for oral administration: Pharmaceutical and pharmacodynamics evaluation.
    Alshora D; Ibrahim M; Alanazi N; Alowyid M; Ali Alnakhli Z; Mohammed Alshiban N; Maodaa S; Alyami NM; Alotaibi I
    Saudi Pharm J; 2023 Dec; 31(12):101830. PubMed ID: 38028219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and evaluation of proniosomes containing lornoxicam.
    Madan JR; Ghuge NP; Dua K
    Drug Deliv Transl Res; 2016 Oct; 6(5):511-8. PubMed ID: 27255375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proniosomes as a drug carrier for transdermal delivery of ketorolac.
    Alsarra IA; Bosela AA; Ahmed SM; Mahrous GM
    Eur J Pharm Biopharm; 2005 Apr; 59(3):485-90. PubMed ID: 15760729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review on novel vesicular drug delivery: proniosomes.
    Yasam VR; Jakki SL; Natarajan J; Kuppusamy G
    Drug Deliv; 2014 Jun; 21(4):243-9. PubMed ID: 24128089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proniosomes as drug carriers.
    Sankar V; Ruckmani K; Durga S; Jailani S
    Pak J Pharm Sci; 2010 Jan; 23(1):103-7. PubMed ID: 20067875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro skin permeation of estradiol from various proniosome formulations.
    Fang JY; Yu SY; Wu PC; Huang YB; Tsai YH
    Int J Pharm; 2001 Mar; 215(1-2):91-9. PubMed ID: 11250095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Review on Proniosomes: A Propitious Outlook to the Provesicular Drug Delivery System.
    Saxena A; Apurvi P; Aslam R
    Curr Drug Deliv; 2023; 20(8):1115-1126. PubMed ID: 36278459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo evaluation of proniosomes containing celecoxib for oral administration.
    Nasr M
    AAPS PharmSciTech; 2010 Mar; 11(1):85-9. PubMed ID: 20058106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proniosomal powder of captopril: formulation and evaluation.
    Gupta A; Prajapati SK; Singh M; Balamurugan M
    Mol Pharm; 2007; 4(4):596-9. PubMed ID: 17472398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Developments in Proniosomal Transdermal Drug Delivery: An Overview.
    Sabale V; Charde M; Dumore N; Mahajan U
    Curr Drug Deliv; 2023; 20(6):683-693. PubMed ID: 35466874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Evaluation of Optimized Thiolated Chitosan Proniosomal Gel Containing Duloxetine for Intranasal Delivery.
    Khatoon M; Sohail MF; Shahnaz G; Ur Rehman F; Fakhar-Ud-Din ; Ur Rehman A; Ullah N; Amin U; Khan GM; Shah KU
    AAPS PharmSciTech; 2019 Aug; 20(7):288. PubMed ID: 31410741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation by design-based proniosome for accentuated transdermal delivery of risperidone: in vitro characterization and in vivo pharmacokinetic study.
    Imam SS; Aqil M; Akhtar M; Sultana Y; Ali A
    Drug Deliv; 2015 Dec; 22(8):1059-1070. PubMed ID: 24471715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and in vitro permeation studies of proniosomal based transdermal delivery system of Atenolol.
    Ramkanth S; Chetty CM; Sudhakar Y
    Pak J Pharm Sci; 2014 Jan; 27(1):115-20. PubMed ID: 24374439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement in antinociceptive and anti-inflammatory effects of tramadol by transdermal proniosome gel.
    Shah J; Nair AB; Shah H; Jacob S; Shehata TM; Morsy MA
    Asian J Pharm Sci; 2020 Nov; 15(6):786-796. PubMed ID: 33363633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.